A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis
Conditions:   Systemic Sclerosis;   Gastroesophageal Reflux;   Proton Pubm Inhibitor Intervention:   Drug: Omeprazole 20mg Sponsors:   Khon Kaen University;   Thai Rheumatism Association Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis
Conditions:   Systemic Sclerosis;   Gastroesophageal Reflux;   Proton Pubm Inhibitor Intervention:   Drug: Omeprazole 20mg Sponsors:   Khon Kaen University;   Thai Rheumatism Association Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis
Conditions:   Systemic Sclerosis;   Gastroesophageal Reflux;   Proton Pubm Inhibitor Intervention:   Drug: Omeprazole 20mg Sponsors:   Khon Kaen University;   Thai Rheumatism Association Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials

Antireflux Ablation Therapy (ARAT) for Gastroesophageal Reflux Treatment
Condition:   Gastro Esophageal Reflux Intervention:   Procedure: ARAT Sponsor:   Coordinación de Investigación en Salud, Mexico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2018 Category: Research Source Type: clinical trials

Utilization of Anti-reflux Treatment and Course of Illness Leading to Reoperation
Conditions:   GERD;   Fundoplication Intervention:   Sponsors:   University of Southern Denmark;   OPEN - Odense Patient Data Exploratory Network;   Kolding Sygehus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2018 Category: Research Source Type: clinical trials

Treatment of Newly Diagnosed Gastroesophageal Reflux Disease in a National Population-based Cohort
Condition:   Gastroesophageal Reflux Intervention:   Sponsors:   University of Southern Denmark;   Kolding Sygehus;   OPEN - Odense Patient Data Exploratory Network Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2018 Category: Research Source Type: clinical trials